| 摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: invention relates to the field of molecular biology, genetic engineering and medicine.EFFECT: claimed is a molecule of ribonucleic acid, mediating the RNA interference, aimed against PKN3, as well as a lipocomplex, containing thereof, a pharmaceutical composition, application and method of treating cancer disease involving the PI3-kinase pathway.48 cl, 2 tbl, 17 dwg, 13 ex |
